In a later report [50], the researchers revealed that the overexpression of nSMase2 in murine breast cancer cells led to an increase in the number of exosomes and exosomal miRNAs miR-16 and miR-210, while inhibiting nSMase2 had the opposite effect. This evidence concerns the gene SMPD3 and breast carcinoma.